HWAM
AGIO icon

Hennion & Walsh Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Hennion & Walsh Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Sell
33,574
-294
-0.9% -$8.92K 0.04% 507
2026
Q1 		$1.15M Buy
33,868
+398
+1% +$11.3K 0.04% 471
2025
Q4 		$911K Buy
33,470
+7,969
+31% +$280K 0.03% 542
2025
Q3 		$1.02M Buy
25,501
+10,496
+70% +$395K 0.04% 506
2025
Q2 		$499K Buy
+15,005
New +$455K 0.02% 672
2023
Q2 		– Sell
-22,525
Closed -$517K – 798
2023
Q1 		$517K Sell
22,525
-772
-3% -$20.5K 0.03% 498
2022
Q4 		$654K Buy
23,297
+2,944
+14% +$83K 0.04% 436
2022
Q3 		$576K Sell
20,353
-282
-1% -$7.56K 0.04% 453
2022
Q2 		$457K Sell
20,635
-307
-1% -$6.93K 0.03% 508
2022
Q1 		$610K Buy
20,942
+427
+2% +$13K 0.03% 471
2021
Q4 		$674K Buy
20,515
+1,283
+7% +$51.6K 0.03% 464
2021
Q3 		$888K Buy
19,232
+6,586
+52% +$318K 0.05% 375
2021
Q2 		$697K Sell
12,646
-2,735
-18% -$153K 0.04% 444
2021
Q1 		$794K Buy
+15,381
New +$762K 0.05% 410

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Hennion & Walsh Asset Management's AGIO Position: Q2 2026 in Review

Hennion & Walsh Asset Management reduced its Agios Pharmaceuticals (AGIO) stake by 0.87% in Q2 2026, selling an estimated $8.92K and leaving 33,574 shares worth $1.25M. The position accounts for 0.04% of the portfolio, ranked #507.

Hennion & Walsh Asset Management first reported a position in AGIO in Q1 2021 and has held it in 14 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Hennion & Walsh Asset Management held 33,574 shares of Agios Pharmaceuticals worth $1.25M as of Q2 2026.
  • Hennion & Walsh Asset Management sold 294 Agios Pharmaceuticals shares in Q2 2026, an estimated $8.92K.
  • Agios Pharmaceuticals made up 0.04% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #507 holding.
  • Hennion & Walsh Asset Management first reported a position in Agios Pharmaceuticals in Q1 2021 and has held it in 14 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.